[{"orgOrder":0,"company":"Nordic Biotic Sp. z o.o.","sponsor":"Medical University of Lublin","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Bifidobacterium Lactis","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Nordic Biotic Sp. z o.o.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nordic Biotic Sp. z o.o. \/ Medical University of Lublin","highestDevelopmentStatusID":"1","companyTruncated":"Nordic Biotic Sp. z o.o. \/ Medical University of Lublin"}]

Find Clinical Drug Pipeline Developments & Deals for Bifidobacterium Lactis

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Nordic Biotic Sp. z o.o.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Nordic Biotic Sp. z o.o.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          October 01, 2021

                          Lead Product(s) : Bifidobacterium Lactis

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Medical University of Lublin

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank